Company / R&D per Share
LIXTE BIOTECHNOLOGY HOLDINGS, INC. R&D per Share History
FY2011-FY2015 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.02
FY2015
5-year range
$0.01 / $0.05
FY2011-FY2015
Trend
-39.3%
vs FY2014
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.05 to $0.02 over the past 3 years.
Based on SEC 10-K filings.
0.02 in FY2015 with a 3-year CAGR of -22.8%.
Declined from $0.05 to $0.02 over the past 3 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -22.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2015, r&d per share decreased 39.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2015 | $0.02 | -39.3% |
| FY2013 | $0.04 | -24.2% |
| FY2012 | $0.05 | +320.3% |
| FY2011 | $0.01 | - |
As of FY2015 · SEC 10-K · Updated Jun 24, 2026